Summary by Moomoo AI
KOCHI PHARMACEUTICAL-B (02171.HK) CONDUCTED A SHARE REPURCHASE ACTIVITY ON MAY 31, 2024, ACCORDING TO THE LISTING RULES DISCLOSED BY THE STOCK EXCHANGE OF HONG KONG STOCK EXCHANGE LIMITED. The company repurchased 400,000 shares of common stock, representing 0.069% of its shares issued prior to the repurchase. The buyback was priced at HK$6.87 per share, with a total cost of HK$2,748,000. After the repurchase, the issued share capital of Kozai Pharmaceuticals remained at 575,643,915 shares. The Company confirms that this share repurchase has been approved by the Board of Directors and complies with all relevant legal requirements and listing rules.